Abstract:Key PointsInnate lymphoid cells (ILCs) are newly identified members of the lymphoid lineage with emerging roles in mediating immune responses and in regulating tissue homeostasis and inflammation.The existence of different ILC populations that can rapidly secrete immunoregulatory cytokines suggests that these cells may have evolved to provide immunity to infections. Indeed, it is notable that ILC subsets seem to be particularly prevalent at mucosal surfaces, which are constantly exposed to infectious agents in the external environment.The group 1 ILC lineage comprises ILCs such as natural killer (NK) cells that produce type 1 cytokines, notably interferon-γ and tumour necrosis factor. Other group 1 ILCs have been reported, mainly in vitro, and their physiological roles remain to be defined.The group 2 ILC population comprises ILC2s, which express interleukin-5 (IL-5) and IL-13 and require GATA-binding protein 3 (GATA3) and retinoic acid receptor-related orphan receptor-α (RORα) for their development. They have crucial roles in protective type 2 immunity to helminth infection. Furthermore, although T helper 2 cells are a major source of type 2 cytokines during allergic asthma, ILC2s also contribute to disease pathology.ILC3s were first defined as intestinal lymphoid cells that express the NK cell activating receptor NKp46, but otherwise bear little functional resemblance to conventional NK cells, and require RORγ for their development. They express IL-17A and IL-22.Recent studies have also implicated ILC3s in the development of inflammatory bowel disease. Studies in Rag2−/− mice demonstrated that, in the early phase of Citrobacter rodentium infection, IL-22 is produced from an innate cell source.Lymphoid tissue-inducer (LTi) cells are an ILC subset that appears to be closely related to ILC3s, but their exact relationship remains controversial. Together, LTi cells and ILC3s have been classified as group 3 ILCs.

Ambiguous roles of innate lymphoid cells in chronic development of liver diseases

The Role of Innate Lymphoid Cells in Immune-Mediated Liver Diseases.

The Role of ILC3 in Intestinal Immunity

The Origin and Role of Innate Lymphoid Cells in the Lung

Innate Lymphoid Cells and Inflammatory Bowel Disease

Innate Lymphoid Cells in Crohn’s Disease

Innate-like T cells in liver disease

Innate Lymphoid Cells in Crohn's Disease

Type 3 Innate Lymphoid Cell: a New Player in Liver Fibrosis Progression

The role of innate lymphoid cells in inlfammatory dermatosis

Functional interactions between innate lymphoid cells and adaptive immunity

[Research Progress on the Role of Type II Innate Lymphoid Cells in Liver Diseases].

Liver type 1 innate lymphoid cells develop locally via an interferon-γ–dependent loop

Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer

Group 1 ILCs regulate T cell-mediated liver immunopathology by controlling local IL-2 availability

ILC3 Function As a Double-Edged Sword in Inflammatory Bowel Diseases

Innate-like T lymphocytes in chronic liver disease

ILC in chronic inflammation, cancer and targeting with biologicals

Differential Phenotypic and Functional Properties of Liver-Resident NK Cells and Mucosal ILC1s.

Innate lymphoid cells — how did we miss them?

Parallel origins and functions of T cells and ILCs